Secondary retensioning of a tether-based device for transapical transcatheter mitral valve implantation.
Martin BeyerDavid MullerFederico De MarcoVinay BadhwarJean-Francois ObadiaFabien PrazThomas ModinePim ToninoGry DahleAlfredo CerilloSebastian LudwigLenard ConradiPublished in: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery (2024)
This multicentre study demonstrates technical feasibility, procedural safety and acute efficacy of retensioning procedures in the majority of patients. The potential to retension the tether in transapical TMVI may provide additional management advantages in populations at high surgical risk.
Keyphrases
- mitral valve
- end stage renal disease
- left atrial
- ejection fraction
- transcatheter aortic valve replacement
- transcatheter aortic valve implantation
- newly diagnosed
- chronic kidney disease
- left ventricular
- liver failure
- peritoneal dialysis
- prognostic factors
- respiratory failure
- heart failure
- intensive care unit
- risk assessment
- patient reported outcomes
- extracorporeal membrane oxygenation
- aortic stenosis
- coronary artery disease
- acute respiratory distress syndrome